This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IMRIS Sponsors Symposium At Major Neurosurgical Conference

WINNIPEG, April 10, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that it is hosting its first-ever satellite symposium at the annual meeting of the American Association of Neurological Surgeons at AANS 2012 in Miami Beach, FL.  The symposium, which takes place on April 16, 2012, will be chaired by Dr. Joseph Piepmeier, Chief of the Section of Surgical Neuro-oncology at Yale University School of Medicine.  Entitled "Clinical Applications and Future Direction of iMRI in Neurosurgery", the program will feature presentations from four surgeons who will share their experiences and clinical findings in a range of neurosurgical applications.  The event is limited to healthcare professionals and over 100 clinicians are expected to attend.

As part of the AANS Scientific Sessions on April 17, 2012, Dr. Xiaolei Chen, Associate Professor, Neurosurgery, Chinese PLA General Hospital, Beijing, will be presenting the preliminary results of the first randomized trial that studied the resection of low-grade insular glioma using high-field intraoperative MR imaging.  Dr. Chen's presentation is one of several that indicate that intraoperative MR imaging is gaining broad acceptance as a "best clinical practice" in neurosurgery.  In fact, all oral presentations on intraoperative MR imaging at AANS 2012 are based on studies at hospitals with VISIUS Surgical Theatres. Recognizing the increasing attention to this technology, AANS created a new course for this year's annual meeting on intraoperative imaging, including MR, as well as angiographic, fluoroscopic and CT modalities.

IMRIS returns to the exhibition hall at AANS 2012 with a comprehensive booth (#835) demonstrating the VISIUS Surgical Theatre and its integrated technologies optimized for intraoperative imaging in a neurosurgical environment.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs